NexgenRx Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was CAD 12.78 million compared to CAD 11.84 million a year ago. Net loss was CAD 0.022401 million compared to net income of CAD 4.02 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 CAD | +1.75% | +1.75% | +31.82% |
May. 17 | NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 16 | Charles Burns Tenders Resignation as Director of NexgenRx Inc | CI |
1st Jan change | Capi. | |
---|---|---|
+31.82% | 15M | |
-2.82% | 117B | |
+8.08% | 100B | |
+11.08% | 66.73B | |
+22.20% | 66.16B | |
+13.14% | 44.04B | |
+12.59% | 42.48B | |
+22.35% | 36.43B | |
+8.52% | 26.09B | |
-3.83% | 22.44B |
- Stock Market
- Equities
- NXG Stock
- News NexgenRx Inc.
- NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022